Myron W. Shulgan
CIK: 0002038614
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)2 (100.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
About Shulgan Myron W.
Shulgan Myron W. (SEC CIK 0002038614) files insider reports with the SEC as Director of Drugs Made In America Acquisition II Corp. (DMII) and Director of Drugs Made In America Acquisition Corp. (DMAA).
Signal8 holds 4 ownership filings by Shulgan Myron W. (2 Form 3, 2 Form 4), filed between Jan 10, 2025 and Oct 2, 2025. Those filings report 2 transactions, from Jan 29, 2025 to Sep 26, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Shulgan Myron W.'s filings is in FORT LAUDERDALE, FL.
Recent filings by Shulgan Myron W.
Other insiders filing for Drugs Made In America Acquisition II Corp. (DMII)
- Do Catherine, Director
- Worman Glenn C., CFO
- Stockwell Lynn, CEO and Exe. Chair of Board
- Drugs Made In America Acquisition II LLC, 10% Owner
- Prasad Sridhar G., Director